These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 33170687)

  • 1. Synthesis and Pharmacology of a Novel μ-δ Opioid Receptor Heteromer-Selective Agonist Based on the Carfentanyl Template.
    Faouzi A; Uprety R; Gomes I; Massaly N; Keresztes AI; Le Rouzic V; Gupta A; Zhang T; Yoon HJ; Ansonoff M; Allaoa A; Pan YX; Pintar J; Morón JA; Streicher JM; Devi LA; Majumdar S
    J Med Chem; 2020 Nov; 63(22):13618-13637. PubMed ID: 33170687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a μ-δ opioid receptor heteromer-biased agonist with antinociceptive activity.
    Gomes I; Fujita W; Gupta A; Saldanha SA; Negri A; Pinello CE; Eberhart C; Roberts E; Filizola M; Hodder P; Devi LA
    Proc Natl Acad Sci U S A; 2013 Jul; 110(29):12072-7. PubMed ID: 23818586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of delta-opioid receptor trafficking via mu-opioid receptor stimulation: evidence from mu-opioid receptor knock-out mice.
    Morinville A; Cahill CM; Esdaile MJ; Aibak H; Collier B; Kieffer BL; Beaudet A
    J Neurosci; 2003 Jun; 23(12):4888-98. PubMed ID: 12832511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel fentanyl-based dual μ/δ-opioid agonists for the treatment of acute and chronic pain.
    Podolsky AT; Sandweiss A; Hu J; Bilsky EJ; Cain JP; Kumirov VK; Lee YS; Hruby VJ; Vardanyan RS; Vanderah TW
    Life Sci; 2013 Dec; 93(25-26):1010-6. PubMed ID: 24084045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular characterization of eluxadoline as a potential ligand targeting mu-delta opioid receptor heteromers.
    Fujita W; Gomes I; Dove LS; Prohaska D; McIntyre G; Devi LA
    Biochem Pharmacol; 2014 Dec; 92(3):448-56. PubMed ID: 25261794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The δ opioid receptor agonist SNC80 selectively activates heteromeric μ-δ opioid receptors.
    Metcalf MD; Yekkirala AS; Powers MD; Kitto KF; Fairbanks CA; Wilcox GL; Portoghese PS
    ACS Chem Neurosci; 2012 Jul; 3(7):505-9. PubMed ID: 22860219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinically employed opioid analgesics produce antinociception via μ-δ opioid receptor heteromers in Rhesus monkeys.
    Yekkirala AS; Banks ML; Lunzer MM; Negus SS; Rice KC; Portoghese PS
    ACS Chem Neurosci; 2012 Sep; 3(9):720-7. PubMed ID: 23019498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of the Mu-Delta Opioid Receptor Heteromers Blocks Morphine Rewarding Effects.
    Requana Aradas A; Djaboub Y; McCort-Tranchepain I; Hajasova Z; Clémenceau L; Canestrelli C; Mann A; Schulz S; Delaval A; Acher F; Massotte D; Noble F; Marie N
    Int J Neuropsychopharmacol; 2023 Jul; 26(7):513-521. PubMed ID: 37343217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antidepressant-like and anxiolytic-like effects following activation of the μ-δ opioid receptor heteromer in the nucleus accumbens.
    Kabli N; Nguyen T; Balboni G; O'Dowd BF; George SR
    Mol Psychiatry; 2014 Sep; 19(9):986-94. PubMed ID: 24061495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mu-opioid receptor knockout prevents changes in delta-opioid receptor trafficking induced by chronic inflammatory pain.
    Morinville A; Cahill CM; Kieffer B; Collier B; Beaudet A
    Pain; 2004 Jun; 109(3):266-273. PubMed ID: 15157687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heteromers of μ-δ opioid receptors: new pharmacology and novel therapeutic possibilities.
    Fujita W; Gomes I; Devi LA
    Br J Pharmacol; 2015 Jan; 172(2):375-87. PubMed ID: 24571499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged morphine treatment targets delta opioid receptors to neuronal plasma membranes and enhances delta-mediated antinociception.
    Cahill CM; Morinville A; Lee MC; Vincent JP; Collier B; Beaudet A
    J Neurosci; 2001 Oct; 21(19):7598-607. PubMed ID: 11567050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors.
    Yamada H; Shimoyama N; Sora I; Uhl GR; Fukuda Y; Moriya H; Shimoyama M
    Brain Res; 2006 Apr; 1083(1):61-9. PubMed ID: 16530171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Competitive and non-competitive NMDA antagonists block the development of antinociceptive tolerance to morphine, but not to selective mu or delta opioid agonists in mice.
    Bilsky EJ; Inturrisi CE; Sadée W; Hruby VJ; Porreca F
    Pain; 1996 Dec; 68(2-3):229-37. PubMed ID: 9121809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agonists at the δ-opioid receptor modify the binding of µ-receptor agonists to the µ-δ receptor hetero-oligomer.
    Kabli N; Martin N; Fan T; Nguyen T; Hasbi A; Balboni G; O'Dowd BF; George SR
    Br J Pharmacol; 2010 Nov; 161(5):1122-36. PubMed ID: 20977461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical opioids differentially induce co-internalization of μ- and δ-opioid receptors.
    Bao F; Li CL; Chen XQ; Lu YJ; Bao L; Zhang X
    Mol Pain; 2018; 14():1744806918769492. PubMed ID: 29587571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antinociceptive effects of the 6-O-sulfate ester of morphine in normal and diabetic rats: Comparative role of mu- and delta-opioid receptors.
    Yadlapalli JSK; Ford BM; Ketkar A; Wan A; Penthala NR; Eoff RL; Prather PL; Dobretsov M; Crooks PA
    Pharmacol Res; 2016 Nov; 113(Pt A):335-347. PubMed ID: 27637375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dextromethorphan and ketamine potentiate the antinociceptive effects of mu- but not delta- or kappa-opioid agonists in a mouse model of acute pain.
    Baker AK; Hoffmann VL; Meert TF
    Pharmacol Biochem Behav; 2002 Dec; 74(1):73-86. PubMed ID: 12376154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of delta-opioid receptor contributes to the antinociceptive effect of oxycodone in mice.
    Yang PP; Yeh GC; Yeh TK; Xi J; Loh HH; Law PY; Tao PL
    Pharmacol Res; 2016 Sep; 111():867-876. PubMed ID: 27496654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
    Wells JL; Bartlett JL; Ananthan S; Bilsky EJ
    J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.